Journey Medical Corporation (DERM)

NASDAQ: DERM · USD

$5.06

+0.10 (+2.0%)· Recorded snapshot

Market cap	142.8M
Revenue (ttm)	68.2M
Net income (ttm)	-6.1M
EPS (ttm)	-$0.23
Shares out	28.2M
P/E (forward)	45.1x
Volume	163,155
Beta	1.11

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 68.2M
Net income (ttm): -6.1M
EPS (ttm): -$0.23
P/E (forward): 45.1x
Market cap: 142.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E45.1

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-23.8

P25 -113.8P50 -46.5P75 -0.9

ROIC-9.8

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All DERM indicators

Market & fundamental data

Available fields

211

Groups with data

Currency

USD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001867066
Company name	Journey Medical Corporation
Country	United States
Country code	US
CUSIP number	48115J109
Earnings date	2026-11-11
Earnings time	amc
Employees	58
Employees change	17
Employees growth	41.46%
Enterprise value	$142.7M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2014
Industry	Drug Manufacturers - Specialty & Generic
IPO date	2021-11-12
Is primary listing	Yes
Is SPAC	No
ISIN number	US48115J1097
Last 10-K release date	2026-03-26
Last earnings date	2026-08-12
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$142.8M
Market cap category	Micro-Cap
Next earnings date	2026-11-11
Options	Yes
Price	$5.06
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	DERM
U.S. state	Arizona
Website	https://journeymedicalcorp.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-4.51%
EV/EBITDA	117.6x
EV/Sales	2.1x
FCF / EV yield	-5.24%
FCF yield	-5.24%
Forward EV/Sales	1.48x
Forward P/E	45.09x
Forward P/S	1.48x
Industry forward P/E	13.86x
Industry P/E	173.47x
P/B ratio	4.27x
P/S ratio	2.1x
Price / tangible book value	21.67x
Price/EBITDA ratio	117.68x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-4.41%
EBITDA margin	1.78%
Gross margin	65.45%
Operating margin	-4.41%
Pretax margin	-8.93%
Profit margin	-8.95%
Profit per employee	$-105,241
Revenue per employee	$1.2M
ROA	-2.09%
ROA (5Y)	-9.75%
ROCE	-5.72%
ROE	-23.77%
ROE (5Y)	-81.16%
ROIC	-9.85%
SBC / revenue	8.88%
Tax / revenue	0.02%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	1
Gross profit growth	18.95%
Gross profit growth (Q)	22.81%
Gross profit growth 3Y	11.71%
Gross profit growth 5Y	7.33%
Net income growth quarters	2
Net income growth years	1
Revenue growth	20.9%
Revenue growth (Q)	23.33%
Revenue growth (QoQ)	15.97%
Revenue growth 3Y	3.52%
Revenue growth 5Y	6.75%
Revenue growth quarters	6
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	$4.2M
EBIT	$-3M
EBITDA	$1.2M
EPS	$-0.23
FCF per share	$-0.27
Financing cash flow	$12.8M
Free cash flow	$-7.5M
Free cash flow minus SBC	$-13.5M
Gross profit	$44.6M
Income taxes	$15,000
Net cash flow	$5.4M
Net income	$-6.1M
Operating cash flow minus SBC	$-13.5M
Operating income	$-3M
Revenue	$68.2M
Stock-based compensation	$6.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.19
Book value per share	$1.16
Debt / EBITDA	19.32
Debt / equity	0.8
Interest coverage	-0.82
Long-term assets	$25.6M
Long-term liabilities	$20.5M
Net cash (debt)	$102,000
Net cash / market cap	0.07%
Net debt / EBITDA	-0.08
Net debt / equity	-0
Piotroski F-Score	2
Property, plant and equipment	$65,000
Shareholders' equity	$32.1M
Tangible book value	$6.6M
Tangible book value per share	$0.24
Total assets	$98.4M
Total cash	$25.6M
Total debt	$25.5M
Total liabilities	$66.2M
WACC	10.51%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.76
Current assets	$72.8M
Current liabilities	$45.8M
Current ratio	1.59
Inventory turnover	2.24
Net working capital	$6.4M
Quick ratio	1.35
Working capital	$27M
Working capital turnover	3.61

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-21.63%
Dividend yield	0%
Shareholder yield	-21.63%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$6.20
1D price change	2.02%
1M price change	-18.57%
1M total return	-18.57%
1W price change	-4.21%
1W total return	-4.21%
1Y price change	-37.66%
1Y return CAGR	-37.68%
1Y total return	-37.66%
20-day SMA	$5.58
200-day SMA	$6.67
3M price change	-21.51%
3M total return	-21.51%
3Y price change	59.24%
3Y return CAGR	16.77%
3Y total return	59.24%
50-day SMA	$6.59
50-day SMA vs 200-day SMA	50under200
52-week high	$9.56
52-week high date	2026-01-23
52-week low	$4.31
52-week low date	2026-03-30
6M price change	-4.94%
6M total return	-4.94%
All-time high	$10.20
All-time high date	2021-11-12
All-time low	$1.02
All-time low date	2023-05-18
Average true range (ATR)	$0.35
Average volume	191.5K
Beta (1Y)	1.69
Beta (2Y)	0.4
Beta (5Y)	1.11
Change from 52-week high	-47.04%
Change from 52-week low	17.4%
Change from all-time high	-50.98%
Change from all-time low	390.2%
Change from open	0.6%
Day's gap	1.41%
Dollar volume	$825,564
High price	$5.06
Low price	$4.95
Monthly RSI	43.82
Open price	$5.03
Position in 52-week range	100%
Premarket change	-2.22%
Premarket close	$4.96
Premarket price	$4.85
Premarket volume	840
Previous close	$4.96
Price vs 150-day SMA	-19.35%
Price vs 20-day SMA	-10.38%
Price vs 200-day SMA	-25.02%
Price vs 50-day SMA	-24.14%
Relative volume	0.85
Return from IPO open	-41.72%
Return from IPO price	-49.3%
RSI	34.82
Sharpe ratio	-0.42
Sharpe ratio (3Y)	0.52
Sortino ratio	-0.47
Sortino ratio (3Y)	0.85
Volume	163.2K
Weekly RSI	38.22
YTD price change	-35.15%
YTD total return	-35.15%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15.6M
Float percentage	55.25%
Shares change (QoQ)	0.69%
Shares change (YoY)	21.63%
Shares held by insiders	11.59%
Shares held by institutions	36.22%
Shares outstanding	28.2M
Short % of float	19.16%
Short % of shares	10.59%
Short ratio	17.6 days

Deeper analysis on DERM

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this DERM report

Is a complete DERM research report available?

No complete published report is available for Journey Medical Corporation (DERM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Journey Medical Corporation (DERM)

Price

Financial snapshot

Fair-value bridge

Latest news · DERM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All DERM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on DERM

Frequently asked questions